<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6794">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03018470</url>
  </required_header>
  <id_info>
    <org_study_id>2017/015/SC</org_study_id>
    <nct_id>NCT03018470</nct_id>
  </id_info>
  <brief_title>Change in Breathing Pattern on Non-invasive Ventilation of COPD Patients Under Home Mechanical Ventilation</brief_title>
  <official_title>Usefulness of built-in Non-invasive Ventilator Software to Detect the Change in the Breathing Pattern of COPD Patients Under Home Mechanical Ventilation Before an Admission for Acute Exacerbation of COPD.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute exacerbation of COPD (AECOPD) worsen prognosis and quality of life of COPD patients.
      Telemonitoring could be a useful tool for early identification of AECOPD. Parameters that
      have to be monitored are not well defined.

      Patients with severe COPD may use home non-invasive ventilation (NIV). NIV have built-in
      software which are recording the breathing pattern of patients when used. The aim of this
      study is to identify ventilation parameters that are modified at the early stage of an
      AECOPD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of respiratory rate at the early onset of AECOPD</measure>
    <time_frame>10 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of tidal volume at the early onset of AECOPD</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of leaks at the early onset of AECOPD</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of length of use of NIV at the early onset of AECOPD</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of number of breaks during the use of NIV at the early onset of AECOPD</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of proportion of triggered breaths during the use of NIV at the early onset of AECOPD</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of proportion of asynchronisms during the use of NIV at the early onset of AECOPD</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the number of residual respiratory events during the use of NIV at the early onset of AECOPD</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the inspiratory time during the use of NIV at the early onset of AECOPD</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and specificity of change in the breathing pattern under NIV to detect an AECOPD</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between the change in symptoms and in the breathing pattern under NIV</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between the length of the change in the breathing pattern under NIV and the length of inpatient stay</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between the importance of the change in the breathing pattern under NIV and the severity of the AECOPD</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Copd</condition>
  <condition>COPD Exacerbation</condition>
  <arm_group>
    <arm_group_label>Control cohort</arm_group_label>
    <description>Patient with COPD and home NIV admitted for planned respiratory review and without any sign of exacerbation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exacerbation cohort</arm_group_label>
    <description>Patient with COPD and home NIV admitted for acute exacerbation of COPD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Outpatient exacerbation</arm_group_label>
    <description>Patient with COPD and home NIV admitted for planned respiratory review and with signs of acute exacerbation of COPD but not requiring inpatient management</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Analysis of data from NIV built-in software</intervention_name>
    <description>Analysis of breathing pattern using data obtained from NIV built-in software</description>
    <arm_group_label>Control cohort</arm_group_label>
    <arm_group_label>Exacerbation cohort</arm_group_label>
    <arm_group_label>Outpatient exacerbation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients admitted to Rouen Respiratory unit with established COPD and home
        non invasive ventilation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed COPD according to GOLD guidelines

          -  Established on home non invasive ventilation for more than 2 weeks

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maxime Patout, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Rouen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antoine Cuvelier, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Rouen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sophie Blouet</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Rouen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maxime Patout, MD</last_name>
    <phone>0232889083</phone>
    <phone_ext>69237</phone_ext>
    <email>maxime.patout@chu-rouen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antoine Cuvelier, MD, PhD</last_name>
    <phone>0232889083</phone>
    <email>antoine.cuvelier@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Pneumologie, Oncologie Thoracique et Soins Intensifs Respiratoires</name>
      <address>
        <city>Rouen</city>
        <state>Normandie</state>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maxime Patout, MD</last_name>
      <phone>0232889083</phone>
      <phone_ext>69237</phone_ext>
      <email>maxime.patout@chu-rouen.fr</email>
    </contact>
    <contact_backup>
      <last_name>Antoine Cuvelier, MD, PhD</last_name>
      <phone>0232889083</phone>
      <email>antoine.cuvelier@chu-rouen.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 10, 2017</lastchanged_date>
  <firstreceived_date>January 10, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>Non invasive ventilation</keyword>
  <keyword>NIV</keyword>
  <keyword>Acute exacerbation COPD</keyword>
  <keyword>AECOPD</keyword>
  <keyword>Telemonitoring</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
